Playback speed
10 seconds
ASCO® 2023 Insights: "Randomized Phase 2 Trial in Metastatic Soft Tissue Sarcoma - Cabozantinib +/- PD-1 and CTLA-4 Inhibition"
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
Brian Van Tine
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
Brian Van Tine
289 views
June 15, 2023
Comments 0
Login to view comments.
Click here to Login